How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,859 results for

E/M Examination Criteria

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. 5-Aminolevulinic Acid Hydrochloride (5-ALA)–Guided Surgical Resection of High-Grade Gliomas

survival • Quality of life • Neurological function • Adverse events Exclusion Criteria • Diagnostic accuracy outcomes (sensitivity, specificity, positive predictive value, negative predictive value) Literature Screening A single reviewer conducted an initial screening of titles and abstracts using Covidence 35 and then obtained the full texts of studies that appeared eligible for review, according to the inclusion criteria. A single reviewer then examined the full-text articles and selected studies (...) review are provided in Table 1. Table 1: Inclusion Criteria for Selected Cochrane Systematic Review (Jenkinson et al) 45 Author, Year Literature Search End Date Population Intervention Comparators Outcomes Study Types Included Jenkinson et al, 2018 45 June 2017 • All ages • Presumed new or recurrent glial tumours from clinical examination and imaging Fluorescence- guided surgery (including 5-ALA) a • Neuronavigation • Intraoperative MRI • Intraoperative ultrasound • Extent of resection • Adverse

2020 Health Quality Ontario

162. Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss

e,m High f,l Low High Abbreviation: ROBIS, Risk of Bias in Systematic Reviews. a Possible risk of bias levels: low, high, unclear. b Single reviewer for data extraction and study quality assessment, with data from 10% of the studies being extracted by two reviewers. c Single reviewer for study selection with another assessing those studies over which there was doubt. d Single reviewer for data extraction and checked by a second reviewer. e Unclear on the number of reviewers for study selection (...) . f Unclear on the number of reviewers for data extraction. g Did not specify inclusion and exclusion criteria. h Appraisal of methodological quality was planned a priori but was not performed. i No description on search dates. j Single reviewer for study selection. k Single reviewer for data extraction and quality assessment. l No assessment of the methodological quality of included studies. Only assessed the evidence based on study designs. m No description of databases searched. Appendices

2020 Health Quality Ontario

163. Subacromial decompression surgery for adults with shoulder pain Full Text available with Trip Pro

workers . van der Windt DA , Thomas E , Pope DP , et al . Occupational risk factors for shoulder pain: a systematic review . Hermans J , Luime JJ , Meuffels DE , Reijman M , Simel DL , Bierma-Zeinstra SM . Does this patient with shoulder pain have rotator cuff disease?: The Rational Clinical Examination systematic review . Whittle S , Buchbinder R . In the clinic. Rotator cuff disease . Brox JI . Regional musculoskeletal conditions: shoulder pain . Gill TK , Shanahan EM , Allison D , Alcorn D , Hill (...) of practical issues related to the decision to have surgery and met all authorship criteria for the present article. We thank them for their time and contribution. Footnotes This BMJ Rapid Recommendation article is one of a series that provides clinicians with trustworthy recommendations for potentially practice changing evidence. BMJ Rapid Recommendations represent a collaborative effort between the MAGIC group ( ) and The BMJ . A summary is offered here and the full version including decision aids

2019 BMJ Rapid Recommendations

164. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy Full Text available with Trip Pro

the benefits and harms of different screening tests for their individual situation. Faecal testing with a faecal immunochemical test (FIT) every year Faecal testing with a faecal immunochemical test (FIT) every two years Endoscopic examination of only the lower part of the colon Endoscopic examination of the entire colon Favours no screening Favours screening Colonoscopy offered if FIT or sigmoidoscopy positive People with an estimated 15 year risk of colorectal cancer below 3% We suggest screening (...) risk. For the full disclaimer wording see BMJ's terms and conditions: Lise M Helsingen , methods co-chair, medical doctor , Per Olav Vandvik , general internist, methodologist , Henriette C Jodal , medical doctor , Thomas Agoritsas , general internist, methodologist , Lyubov Lytvyn , patient partnership liaison , Joseph C Anderson , gastroenterologist , Reto Auer , general practicioner , Silje Bjerkelund Murphy , registered nurse , Majid Abdulrahman Almadi , gastroenterologist , Douglas A Corley

2019 BMJ Rapid Recommendations

165. Routine Human Papilloma Virus (HPV) Testing in Squamous Cell Head and Neck Cancer

. Human papillomavirus in metastatic squamous carcinoma from unknown primaries in the head and neck: A retrospective 7 year study. Exper Molec Pathol. 2009;87(2):94-8. 7. El-Mofty SK, Zhang MQ, Davila RM. Histologic identification of human papillomavirus (HPV)-related squamous cell carcinoma in cervical lymph nodes: a reliable predictor of the site of an occult head and neck primary carcinoma. Head Neck Pathol. 2008;2(3):163-8. 8. Hoffmann M, Gottschlich S, Gorogh T, Lohrey C, Schwarz E, Ambrosch P (...) post-therapy; To define objective tumour response rates to induction chemotherapy and to subsequent radiation-based treatment, per RESIST version 1.1 criteria.; To assess progression- free survival at 2 years; To assess overall survival at 2 years.; To assess locoregional diseas e control at 2 years; To assess distant disease control at 2 years; Assessment of quality-of- life outcomes; To identify additional toxicity of treatment Phase III Trials: The Quarterback Trial: A Randomized Phase III

2020 Cancer Care Ontario

166. Kidney Pre-biopsy medication: Antiplatelet and anticoagulant agents

Pharmacology. 1995;35(3):209-19. 5. Garcia D, Libby E, Crowther MA. The new oral anticoagulants. Blood. 2010;115(1):15-20. 6. Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease. European heart journal. 2006;27(22):2667-74. 7. Burger W, CHEMNITIUS JM, Kneissl G, et al. Low -dose aspirin for secondary cardiovascular prevention –cardiovascular risks after (...) -centre retrospective study of 6,700 renal allograft biopsies performed in 2,362 patients between 2005 and 2014, Baffour et al.(18) examined the association between aspirin use and bleeding events. All biopsies were ultrasound guided and most were protocol biopsies (81.3%). The INR was less than 1.5 and platelet count greater than 50 x 10 9 /L in all patients. Three biopsy cores were obtained from each patient, using a needle size of =18 gauge. Aspirin doses were either 81mg or 325mg. Any bleeding

2020 KHA-CARI Guidelines

167. The Japanese Hypertension Guidelines

r e c o m m e n d s t o s t a r t antihypertensive drug treatment with adults aged under 80 with mild hypertension (Stage 1) who has damage in the target organ (risk factor for cardiovascular disease). However, in those with mild hypertension who has no risk factor, there is no evidence to prove benefit of antihypertensive drug treatment. The Cochrane review [6] evaluated 4 randomized controlled trials for antihypertensive drug treatment in patients with mild hypertension (systolic BP 140-159 (...) The Japanese Hypertension Guidelines Page 36 · MED CHECK December 2019/ Vol.5 No.15 C N o 15 M ED HECK 2 0 1 9 Problems in Selection of Members for Guidelines Hypertension Guidelines Part 1, Part 2 Diovan Scandal High Risk of Death from Tamiflu and Xofluza Editorial The Japanese Hypertension Guidelines 2019 Problems in Selection of Members Review Critical Assessment of Hypertension Guidelines Part 1 Scientific evidence for the hypertension guidelines 2019 is poor Critical Assessment

2020 Med Check - The Informed Prescriber

168. Recommendations for good practice in Ultrasound: Oocyte retrieval Full Text available with Trip Pro

search navigation Article Navigation 2019 Article Contents Article Navigation Recommendations for good practice in ultrasound: oocyte pick up The ESHRE Working Group on Ultrasound in ART Search for other works by this author on: , Arianna D’Angelo Wales Fertility Institute , University Hospital of Wales, Cardiff University, Cardiff, UK Correspondence address. Wales Fertility Institute, University Hospital of Wales, Heath Park, Cardiff CF14 4XW, UK. E-mail: , Search for other works by this author (...) previous surgery (gynaecological surgery for myomas, endometriomas, adhesions). A basic diagnostic US examination also allows for the detection of recent lesions, such as endometrial abnormalities or ovarian cysts, in a timely manner. In addition, such transvaginal diagnostic US is of value to visualize not only the ovaries, but also the uterus and to check for potential difficulties during OPU. The accessibility of the ovaries and follicles and any potential complications or difficulties of the OPU

2020 European Society of Human Reproduction and Embryology

169. The risk of HIV among women after acquiring a sexually transmitted infection (STI) and considerations for their use of PrEP

. 1999;20(3):295–9. Padian NS, Shiboski SC, Glass SO, Vittinghoff E. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: Results from a ten-year study. American Journal of Epidemiology. 1997;146(4):350–7. Calabrese SK, Willie TC, Galvao RW, Tekeste M, Dovidio JF, Safon CB, et al. Current US guidelines for prescribing HIV pre-exposure prophylaxis (PrEP) disqualify many women who are at risk and motivated to use PrEP. Journal of Acquired Immune Deficiency Syndromes (...) that only ten (1.5%) would be eligible for PrEP based on the CDC’s recommended indications criteria (20). Table 1 Guideline Recommendations for PrEP use (related to heterosexual women) Canadian guideline on HIV pre-exposure prophylaxis and non-occupational post-exposure prophylaxis (5) Heterosexual exposure PrEP is recommended for the HIV-negative partner in heterosexual serodiscordant relationships reporting condomless vaginal or anal sex where the HIV-positive partner has a substantial risk of having

2020 Ontario HIV Treatment Network

170. Effectiveness of mental health electronic medical records

solo practices to hospitals EMRs and RHR in general – not specified Not specified Also included use of EHR by people with mental illness Literature review – claims to use Cochrane Guidelines. Do not report number of studies identified; inclusion or exclusion criteria etc. Very poor reporting of review methodology Not specified Golberstein et al. (2018) USA Primary care clinics Mental health e-consult with psychiatry ordered by primary care Specific mental health questions asked by primary Primary (...) al. (32) did not provide any specific details, however, they included published papers that assessed any type of EMRs or EHRs including e-ordering of pathology, imaging and pharmacy. (32) They did not report on different aspects separately. Furthermore, although this review cites Cochrane methodology, they did not report the final number of papers identified for inclusion in the review and they did not report specific inclusion or exclusion criteria, nor did they provide a flowchart describing

2020 Sax Institute Evidence Check

171. Suicide postvention services

the same search string in the other databases using subject headings and keywords. The search was undertaken in April 2019, was not limited by language, and comprised the years 2014 to 2019. Two researchers (KA, KKr) independently assessed titles and abstracts for eligibility. We resolved any disagreement through discussion. Potentially relevant studies were examined against the inclusion and exclusion criteria. The references of retrieved papers and existing reviews were hand searched to identify (...) guidelines 71-82 met the inclusion criteria. We assessed the quality of the included studies with two instruments: the National Health and Medical Research Council (NHMRC) Levels of Evidence 56 and the Quality Assessment Tool for Quantitative Studies. 57 The guidelines were analysed based on the criteria provided in the Appraisal of Guidelines for Research and Evaluation II (AGREE) Instrument. 58 Evidence grading Based on NHMRC Level of evidence 56 , there were two level II studies, two level III-3

2020 Sax Institute Evidence Check

172. Suicide aftercare services

are promising but that a large-scale trial in a clinical population is needed before they would recommend wide roll-out. The remaining three systematic reviews provided narrative analysis only. Like Milner et al. 25 , Luxton 26 examined the effects of brief contact interventions (including letters, postcards, phone contact, visits or email) for people who had presented to hospital (ED or psychiatric units) for suicidal behaviour. Eleven publications met inclusion criteria for eight trials. Three of eleven (...) Suggested Citation: Shand F, Woodward A, McGill K, Larsen M, Torok M et al. Suicide aftercare services: an Evidence Check rapid review brokered by the Sax Institute (www.saxinstitute.org.au) for the NSW Ministry of Health, 2019. Disclaimer: This Evidence Check Review was produced using the Evidence Check methodology in response to specific questions from the commissioning agency. It is not necessarily a comprehensive review of all literature relating to the topic area. It was current at the time

2020 Sax Institute Evidence Check

173. What methods have been effective in promoting uptake of Pre-exposure prophylaxis (PrEP) among individuals at high risk of HIV, excluding men who have sex with men

attend planned parenthood. Journal of Acquired Immune Deficiency Syndromes 79(1) 46-53. Available: http://journals.lww.com/jaids/pages/default.aspx. 11. Aaron E, Blum C, Seidman D, Hoyt MJ, Simone J, Sullivan M, et al. 2018. Optimizing delivery of HIV preexposure prophylaxis for women in the United States. AIDS Patient Care and STDs 32(1) 16-23. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756936/. 12. Farthing H, Rodriguez A, Armstrong M, Iyengar S, Nigh E, Potter J, et al. 2018 (...) 79(9-A(E)) No Pagination Specified. Available: https://academiccommons.columbia.edu/doi/10.7916/D8QZ3TDN. 22. Ojikutu BO, Bogart LM, Mayer KH, Stopka TJ, Sullivan PS, Ransome Y 2019. Spatial Access and Willingness to Use Pre-Exposure Prophylaxis Among Black/African American Individuals in the United States: Cross-Sectional Survey. JMIR Public Health Surveill 5(1) e12405. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378549/. 23. Ojikutu BO, Bogart LM, Higgins-Biddle M, Dale SK, Allen W

2020 Public Health England - Evidence Briefings

174. What research has been done to understand substance misuse within the UK student population, and what interventions have been introduced as a result?

-are-they- taking-them-96383]. 22. Dick S, Whelan E, M. D 2019. A systematic review of the effectiveness of digital interventions for illicit substance misuse harm reduction in third-level students. BMC Public Health [http://www.ncbi.nlm.nih.gov/pubmed/31500618]. 23. NUS 2018. NUS Alcohol Impact. [https://alcoholimpact.nus.org.uk/research]. 24. Holt M, Powell S 2017. Healthy Universities: a guiding framework for universities to examine the distinctive health needs of its own student population. Perspect Public (...) review identified 8 studies (2 from the UK) examining 6 digital interventions aimed at reducing harm from substance misuse in university/college What research has been done to understand substance misuse within the UK student population, and what interventions have been introduced as a result? KLS Evidence Briefing 31 st October 2019 students – most interventions produced at least one positive harm-reduction measure, with no negative effects, but the quality of the included studies was weak (22

2020 Public Health England - Evidence Briefings

175. Employment support for over 50s: Rapid evidence review

-based actions? There is a very considerable evidence base on which to draw, although not all with relevance to place-based employment support for those unemployed or seeking to return to paid work. As an RER, the focus of this review is drawing on and critically reviewing past recently published evidence (2010 and since) and scoping available data. The inclusion criteria and search strategy to address the objectives were agreed with Ageing Better in September 2018 with a specific focus on evidence (...) Better 2019 2.1 Introduction The review was concerned to draw its findings and conclusions from reliable and potentially transferable sources. In practice, the robustness of identified evidence was variable and the quality of evidence (including data sources) we draw on in Chapters 3 and 4 is examined here for: - Its overall range and scope set against the review’s focus on place-based return to work support for over 50s in the UK 13 - The quality of that evidence – looking at the pedigree

2020 The Centre for Ageing Better

176. What is the current evidence for the efficacy of drug consumption rooms?

, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: A retrospective population-based study. The Lancet. 2011;377(9775):1429-37. 8. Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet (London, England). 2005;366(9482):316-8. 9. Kimber J, Dolan K, Wodak A. Survey of drug consumption rooms: Service delivery and perceived public health (...) and amenity impact. Drug and Alcohol Review. 2005;24(1):21-4. 10. Boyd N. Lessons from INSITE, Vancouver's supervised injection facility: 2003-2012. Drugs: Education, Prevention & Policy. 2013;20(3):234-40. 11. Barry CL, Sherman SG, Stone E, Kennedy-Hendricks A, Niederdeppe J, Linden S, et al. Arguments supporting and opposing legalization of safe consumption sites in the U.S. International Journal of Drug Policy. 2019;63:18-22. 12. Milloy MJS, Kerr T, Tyndall M, Montaner J, Wood E. Estimated drug

2020 Public Health England - Evidence Briefings

177. Raising the bar on strength and balance: The importance of community-based provision

assure sessions to support workforce and deliver in line with the evidence base Ensure health and safety, plus risk assessments including emergency plans, are in place Raising the bar | Centre for Ageing Better 7Instructors delivering strength and balance training Understand and respect the scope of practice that your training provides. Ensure that it is informed by evidence Provide clear inclusion criteria to referrers to support appropriate referrals Include conversations about goal setting (...) to attend in the locality but without imparting any information (about health status, medications, contraindications for exercise etc.) to the instructor. Referral A formally agreed system including inclusion and exclusion criteria and aligned with best practice referral processes. Strength and Balance Two components of fitness (there are others) that inform our capacity to be physically active i.e. reduced strength and balance will impact on our ability to perform activities of daily living. Uptake

2020 The Centre for Ageing Better

178. What approaches to performance management and performance appraisal in the workplace are effective for improving organisation outcomes or staff attitudes to the process?

development • Ensure managers involve employees in the appraisal discussions so that their voice can be heard • Check in with employees following appraisal to see how they are responding Feedback and goal orientation also seem to be gaining prominence within PA practice and research (6). A meta-analysis on the impact of PM on performance in public organisations examined 2,188 effects gathered from 49 studies (7). The study examined the effect of the “average” PM system, whether beneficial PM practices can (...) . Benchmarking appears to be an effective method for learning who is performing well – practitioners should emphasise the use of benchmarking over time to provide a valid comparison and replicate success (7). Four criteria for the effectiveness of PA systems have been suggested (8): • utilisation - why PAs are conducted (the reason for the existence of performance appraisals is rarely considered (9)) • qualitative - user’s justice perceptions and fairness of a PA system • quantitative – the psychometric

2020 Public Health England - Evidence Briefings

179. Heritable mutations associated with familial hypercholesterolaemia - Clinical Utility Card application

utility card (CUC). 2. MSAC’s advice to the Minister After considering the strength of the available evidence in relation to comparative safety, clinical effectiveness and cost-effectiveness, MSAC supported MBS listing of genetic testing for heritable mutations associated with familial hypercholesterolaemia in affected individuals meeting defined eligibility criteria, and targeted cascade testing in first and second-degree relatives of those affected individuals with a confirmed genetic diagnosis (...) of the requirements for access to PCSK9 inhibitors (evolocumab) on the Pharmaceutical Benefits Scheme (PBS). Evolocumab was listed on the PBS in March 2016 for homozygous FH patients and in March 2018 for heterozygous FH patients. MSAC considered that likely earlier subsidised access to this therapy for family members testing positive to cascade testing was the main source of expected clinical utility, but noted that this was not included in the assessment. MSAC queried whether the PBS criteria would lead

2020 Medical Services Advisory Committee

180. Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma

Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma Dar Daratumumab with bortezomib and atumumab with bortezomib and de dexamethasone for pre xamethasone for previously treated viously treated multiple m multiple my yeloma eloma T echnology appraisal guidance Published: 10 April 2019 nice.org.uk/guidance/ta573 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our (...) received at least one prior therapy' . Dosage in Dosage in the the mark marketing eting authorisation authorisation Daratumumab 16 mg/kg body weight is administered by intravenous infusion every week for weeks 1 to 9, every 3 weeks for weeks 10 to 24 and every 4 weeks from week 25 onwards. Bortezomib is administered by subcutaneous injection at a dose of 1.3 mg/m 2 twice weekly on days 1, 4, 8 and 11 for 8×21-day cycles. Dexamethasone is administered orally at a dose of 80 mg weekly. Price Price

2019 National Institute for Health and Clinical Excellence - Technology Appraisals

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>